Summary. Administration of epsilon-aminocaproic acid, a fibrinolytic inhibitor, either orally or from an impregnated IUD, had no effect on numbers of implanted embryos, their viability, or their diameters at Day 10 of pregnancy.
Introduction
Intrauterine contraceptive devices (IUDs) have been shown to increase fibrinolytic activity in the uterus of monkeys (Shaw, Cihak & Moyer, 1970) , and in man, rabbits, and rats fitted with IUDs (Larsson, Liedholm, Sjöberg & Âstedt, 1974; Larsson, Liedholm & Âstedt, 1975; Liedholm & Sjöberg, 1977) . A possible role for the fibrinolytic system in producing uterine haemorrhage associated with the use of IUDs has been suggested (Shaw & Moyer, 1974) . Systemic antifibrinolytic therapy has proved beneficial for some patients with menorrhagia (Nilsson & Björkman, 1965; Nilsson & Rybo, 1965 ,1971 ; Vermylen, Verhaegen-Duclerq, Verstraete & Fierens, 1968; Callender, Warner & Cope, 1970) and those with uterine haemorrhage associated with IUDs (Weström & Bengtsson, 1970 ; Kasonde & Bonnar, 1975) . Uterine haemorrhage was less in monkeys fitted with IUDs impregnated with the fibrinolytic inhibitor, epsilon-aminocaproic acid (EACA), than in those with non-impreg¬ nated devices (Shaw, Moyer, Aaronson, Underwood & Forino, 1975) . These findings suggest that the effects of intrauterine medication with fibrinolytic inhibitors, for the purpose of controlling endometrial haemorrhage, merit further study.
Preimplantation blastocysts of rabbits exhibit proteolytic activity when incubated on gelatin films (Denker & Hafez, 1975) . Rat ova have also been shown, by histochemical studies, to have fibrinolytic activity during oviductal transport but not at implantation and the rat decidua exhibits powerful inhibitory activity directed against fibrinolytic activators . These findings suggest that enhancement of fibrinolysis could be a prime contraceptive action of the IUD. Conse¬ quently, the control of IUD-induced bleeding with fibrinolytic inhibitors could facilitate the im¬ plantation mechanism and perhaps nullify the contraceptive action of the IUD. However, McNicol, Fletcher, Alkjaersig & Sherry (1962) have shown that EACA inhibits the incorporation of lysine into cellular protein, and therefore high EACA levels in uterine fluid could alter blastocyst development, and implantation in a way which could promote infertility.
In the present investigation, the effects of EACA on pregnancy in rabbits with and without IUDs were studied to see if EACA altered fertility or IUD contraception.
Materials and Methods
Experiment A : animals without IUDs Twenty-four (24) virgin 6-month-old rabbits weighing from 2500 to 3400 g received an intra¬ muscular injection of 25 i.u. hCG upon arrival, and were kept for 3 weeks before being naturally mated with fertile bucks (Day 0 of pregnancy). Seventeen (17) rabbits were given an oral dose of epsilon-aminocaproic acid (6-amino-hexanoic acid : CalBiochem, Los Angeles, California) four times a day so that the total daily dose was 357 mg/kg body weight. This dose was selected because of the known therapeutic effect in women of the same oral dosage schedule (McNicol & Douglas, 1972 To verify that the drug was present in the blood at an effective level, blood samples (1-5 ml) were withdrawn daily from all 24 rabbits throughout the experimental period and tested for the time taken to inhibit the lysis of a streptokinase-activated euglobulin clot. For this test, 0-5 ml rabbit serum was added to 0-5 ml of a pooled human plasma euglobulin preparation, 0-02 ml streptokinase (2-5 units) and 001 ml bovine thrombin (10 NIH units). The Experiments. Rabbits were laparotomized under pentobarbital anaesthesia and IUDs were in¬ serted through a 2-mm stab wound into the mid-portion of each uterine horn and fixed to the uterine wall by a 5-0 silk suture. After at least 5 days, the rabbits were naturally mated to fertile bucks (Day 0) and killed on Day 10. Non-impregnated (control) IUDs were placed in both uterine horns of 17 rabbits and 9 of these were treated systemically with EACA as described for animals in Group A-2. In another 20 rabbits, a control device was inserted into one uterine horn and an experimental (EACA) device was inserted into the other horn of each animal.
At autopsy the entire genital tract was removed from all the animals tested and the corpora lutea (CL) and the implantation sites were counted on each side. All implantation sites were dissected under a microscope and viability of the embryos was assessed by examining for embryonic heart beats and structural abnormalities.
The results were analysed statistically by x2-tests with continuity correction for the implantation rates and by Student's t test for the diameter of implantations. The probability level selected for significance was 5 %.
Results
As shown in Table 1 , the euglobulin clot lysis inhibition time increased from 20 to 50 min in controls to more than 6 h in all the EACA-treated animals, indicating that the oral treatment of the rabbits led to considerable fibrinolytic activity in the blood. The effects of the two treatment regimens are shown in Table 2 . There was no alteration (P > 0-05) of the implantation rates, the number of viable implanta¬ tions or their diameters at Day 10 of pregnancy in any of the groups.
Oral treatment with EACA of rabbits fitted bilaterally with control IUDs had no statistically 
